Sedation Practices for Intubated Patients with COVID-19 and non-COVID-19 Acute Respiratory Distress Syndrome and its Effects on Clinical Outcomes

Authors

  • Patricia T. Pintac, MD Division of Pulmonary Medicine, Department of Medicine, Philippine General Hospital, University of the Philippines Manila, Manila, Philippines https://orcid.org/0009-0006-7516-6955
  • Albert B. Albay Jr., MD Division of Pulmonary Medicine, Department of Medicine, Philippine General Hospital, University of the Philippines Manila, Manila, Philippines; Division of Critical Care Medicine, Philippine General Hospital, Manila, Philippines

DOI:

https://doi.org/10.47895/

Keywords:

COVID-19, ARDS, sedation practices, intensive care, sedative

Abstract

Objective. To compare the sedation practices of adult intubated patients with COVID-19-related Acute Respiratory Distress Syndrome (C-ARDS) and ARDS from other causes, and their impact on clinical outcomes in a tertiary hospital. 

Methods. We performed a retrospective cohort on the sedation practices of adult intubated patients with C-ARDS and non-C-ARDS admitted to the intensive care unit of a tertiary hospital from January 2021 to December 2021. Electronic medical records were reviewed to obtain sedative use, sedative dosages, clinical outcomes, and complications.

Results. Among the 150 included patients, 112 had C-ARDS, and 38 had non-C-ARDS. The C-ARDS group showed a significant difference with the non-C-ARDS group in terms of BMI (24.11 vs. 21.09 kg/m2, p<0.001), use of higher PEEP (16 vs. 10, p<0.001), and prone positioning (40.18% vs 2.63%, p<0.01). In terms of sedation practice, C-ARDS patients targeted deeper RASS scores (p=0.038), with a significantly higher proportion receiving more than one sedative (82.14% vs. 18.42, p<0.001) than non-C-ARDS patients. Sedation doses for midazolam (78 mg/d vs. 36 mg/d; p=0.01) and propofol (mean 2626±1312.97 mg/d vs. 1742±380.99 mg/d; p=0.007), were significantly higher among C-ARDS versus non-C-ARDS group. Durat ion of hospitalization (9 vs. 20 days; p<0.001) and vent ilator use (7 vs. 14.50 days; p<0.001) were significantly shorter in the C-ARDS group, albeit with a high mortality (100% vs. 89.47%; p=0.004). Shock-requiring pressor was significantly associated with multiple sedation use [OR=15.11 (1.52-2032.89); p=0.017] and combinat ion use of benzodiazepine and non-benzodiazepines [OR=11.51 (1.17-1541.91); p=0.034] in the C-ARDS but not the C-ARDS group.

Conclusion. Patients with C-ARDS had higher sedation requirements in terms of dosage and number of sedat ives. The use of multiple sedatives was significantly associated with shock-requiring pressor. We recommend the development of a sedation protocol to guide sedat ion practices and monitoring of complications in the critically ill.

 

Downloads

Published

09/30/2025

Issue

Section

Articles

How to Cite

1.
Sedation Practices for Intubated Patients with COVID-19 and non-COVID-19 Acute Respiratory Distress Syndrome and its Effects on Clinical Outcomes. Acta Med Philipp [Internet]. 2025 Sep. 30 [cited 2025 Oct. 3];. Available from: https://luna.upm.edu.ph/index.php/acta/article/view/11776

Most read articles by the same author(s)

Similar Articles

11-20 of 725

You may also start an advanced similarity search for this article.